Hava Üsküdar Teke, Çiğdem Karakükcü, Hediye Uğur, Salih Tokmak, Ali Ünal

Dapsone Induced Aplastic Anemia / Dapson Kaynaklı Aplastik Anemi

ABSTRACT: Dapsone is a sulfone antibiotic, which has anti-inflammatory and anti-bacterial effects and used in leprosy, intractable skin lesions, rheumatologic diseases like systemic lupus erythematosus and Pneumocystis jiroveci prophylaxis. Aplastic anemia is an uncommon adverse hematologic effect in patients treated with dapsone. We present a 59 years old female patient which developed aplastic anemia, direct coombs positively and methemoglobinemia because of dapsone. Before starting dapsone treatment, side effect profile must be discussed thoroughly; periodic CBC must be performed before and after the treatment, even without any patient complaints. KEYWORDS: Dapsone, aplastic anemia, hemolysisÖZET: Dapsone, romatolojik hastalıklardan sistemik lupus eritematozis ve Pneumocystis jiroveci proflaksisi ile lepra ve inatçı cilt lezyonlarında kullanılan, anti-inflamatuvar ve antibakteriyel özelliklere sahip bir sülfon antibiyotiktir. Aplastik anemi, dapsonla tedavi edilen hastalarda nadir görülen hematolojik bir yan etkidir. Bu yazıda dapsona bağlı aplastik anemi, direkt coombs pozitifliği ve methemoglobinemi gelişen 59 yaşındaki kadın hastayı sunduk. Dapson başlamadan önce ilacın yan etkileri dikkatli bir şekilde gözden geçirilmeli, ilacı başlamadan önce ve başladıktan sonra periyodik olarak tam kan sayımı yapılmalıdır. ANAHTAR KELİMELER: Dapson, aplastik anemi, hemoliz

Anahtar Kelimeler:

Dapsone, aplastic anemia

PDF

___

1. Plotkin, J. S., Buell, J. F., Njoku, M. J., Wilson, S., Kuo, P. C., Bartlett, S. T., ... & Johnson, L. B. (1997). Methemoglobinemia associated with dapsone treatment in solid organ transplant recipients: A two‐case report and review. Liver Transplantation and Surgery, 3(2), 149-152.
2. Ranawaka, R. R., Mendis, S., & Weerakoon, H. S. (2008). Dapsone-induced haemolytic anaemia, hepatitis and agranulocytosis in a leprosy patient with normal glucose-6-phosphate-dehydrogenase activity. Leprosy review, 79(4), 436.
3. Hörnsten, P., Keisu, M., & Wiholm, B. E. (1990). The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988. Archives of dermatology, 126(7), 919-922.
4. Meyerson, M. A., & COHEN, P. R. (1994, December). Dapsone-induced aplastic anemia in a woman with bullous systemic lupus erythematosus. In Mayo Clinic Proceedings (Vol. 69, No. 12, pp. 1159-1162). Elsevier.
5. Foucauld J, Uphouse W, Berenberg J. (1985). Dapsone and aplastic anemia, Ann Intern Med 102:139
6. Mishra, M., & Chhetia, R. (2006). Dapsone-induced agranulocytosis in a patient of leprosy. Indian Journal of Dermatology, Venereology, and Leprology, 72(6), 456.
7. Machet, L., Callens, A., Mercier, E., Gargot, S., Lorette, G., & Vaillant, L. (1995, December). [Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis]. In Annales de dermatologie et de venereologie (Vol. 123, No. 5, pp. 328-330).